MIRM - Mirum Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MIRM is currently covered by 13 analysts with an average price target of $135.79. This is a potential upside of $50.31 (58.86%) from yesterday's end of day stock price of $85.48.

Mirum Pharmaceuticals's activity chart (see below) currently has 235 price targets and 208 ratings on display. The stock rating distribution of MIRM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 77.95% with an average time for these price targets to be met of 401.82 days.

Highest price target for MIRM is $195, Lowest price target is $94, average price target is $135.79.

Most recent stock forecast was given by BRIAN SKORNEY from BAIRD. First documented stock forecast 11-Aug-2019.

Best performing analysts who are covering MIRM - Mirum Pharmaceuticals:

Yasmeen Rahimi Steven Seedhouse Ed Arce Jonathan Wolleben Gavin Clark-Gartner Joseph Thome

Currently out of the existing stock ratings of MIRM, 46 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Jun-2020

$130

$42.46 (48.50%)

$129

Buy Since 19-Sep-2023

$137

$49.46 (56.50%)

$137

1 months 4 days ago
(26-Aug-2026)

15/21 (71.43%)

$37.25 (37.34%)

415

Buy Since 06-May-2026

$135

$47.46 (54.22%)

$148

1 months 25 days ago
(05-Aug-2026)

0/3 (0%)

$40.88 (43.43%)

Buy Since 23-Sep-2025

$140

$52.46 (59.93%)

$145

1 months 25 days ago
(05-Aug-2026)

3/5 (60%)

$45.88 (48.75%)

112

Show more analysts

Please expand the browser size to see the chart

What is MIRM (Mirum Pharmaceuticals) average time for price targets to be met?

On average it took 402 days for the stock forecasts to be reached, with an average price target met ratio of 77.95%.

Which analyst most recently updated their price target on MIRM (Mirum Pharmaceuticals)?

Brian Skorney

Which analyst has the most public recommendations on MIRM (Mirum Pharmaceuticals)?

Brian Skorney works at BAIRD and has 2 price targets and 1 ratings on MIRM

Which analyst is the currently most bullish on MIRM (Mirum Pharmaceuticals)?

Swayampakula Ramakanth with the highest potential upside of $107.46

Which analyst is the currently most reserved on MIRM (Mirum Pharmaceuticals)?

Joe Ritchie with the lowest potential downside of -$83.2
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?